BCL2L1 and essential thrombocythemia: In 2004, Zhang et al. evaluated the expression of BCL-XL during megakaryocyte differentiation in patients with ET, and noted that the expression of this protein diminished early in in vitro megakaryocyte cell cultures, in the presence of TPO.